Pe Veränderung Datum
AbbVie 23.03 1 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amgen 19.84 5.47 2026-03
AstraZeneca 25.34 4.25 2026-06
Biogen 13.7 0.32 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
GlaxoSmithKline 14.87 3.72 2026-03
J&J 29.43 4.9 2026-06
Merck 16.52 2.6 2026-03
Novartis 22.41 2.24 2026-06
Pfizer 9.32 5.16 2026-03
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Roche Holding 16.48 0.39 2026-06
Xencor 29.92 3.22 2022-09